GET DAILY SIGNALSWhy Is JBS N.V. (JBS) Stock Down -4.80% Today?
Key Takeaways
- Shares fell 4.80% to $12.49, down from the prior session's close of $13.12, following a weaker-than-expected third-quarter earnings report.
- Primary catalyst: Q3 2026 net income plunged 72% year over year to $164 million, with adjusted EBITDA missing Wall Street estimates by a wide margin.
- Secondary drivers: China's filled 2026 beef import quota curbed Brazilian exports, while free cash flow turned negative and net leverage climbed to 3.54x.
- Corporate announcements: Related-party acquisitions of Flora and Canal Rural from controlling shareholder J&F raised governance and dilution concerns.
- Broader context: The move diverged from a largely flat U.S. equity session, highlighting stock-specific pressure in the global protein sector.
- What traders are watching next: Fourth-quarter beef demand, the reopening of the 2027 China quota cycle, and U.S. beef margin recovery.
- Explore Price Targets, Earnings, and Forecast pages for deeper analysis of this ticker.
- Discover Trending AI Robots to see which automated strategies are currently leading the market.
Opening Summary
JBS, the world's largest animal protein processor, is under pressure in Tuesday's session. The stock, traded as JBS N.V. on the NYSE, was down 4.80% to $12.49, compared with the previous close of $13.12. The decline extends a post-market selloff that began after the company reported third-quarter 2026 results on Monday evening, which missed consensus expectations across nearly every key profitability metric. Markets attributed the slide primarily to the earnings miss, compounded by a sharp rise in leverage and the announcement of two related-party acquisitions.
Earnings-Driven Move: A Miss Across Key Metrics
The dominant catalyst for the decline is a disappointing third-quarter report. JBS posted net income of $164 million, down 72% from $581 million a year earlier. Adjusted EBITDA under IFRS fell 36% to $1.18 billion, well below the roughly $1.32 billion analysts had expected, while adjusted earnings per share of $0.15 came in at less than half the consensus estimate of $0.32. Net revenue edged up just 1% to $22.74 billion but also trailed forecasts. The breadth of the shortfall across segments fueled the market reaction, with investors reassessing near-term profitability across the group's global portfolio.
China Quota and Segment Weakness
A key structural headwind was China's beef import quota. Once Brazil filled its 2026 quota earlier in the year, export volumes to the key Chinese market fell sharply, hitting the company's Brazilian unit hardest. Adjusted EBITDA in JBS Brazil dropped 54%, with the segment's margin narrowing to 3.4% from 7.4%. Weakness also extended to U.S. pork, where the margin collapsed to 2.0% from 9.8% on softer domestic demand and ample global supply, and to Pilgrim's Pride, whose adjusted EBITDA fell 40%. JBS Beef North America showed improvement, returning to roughly breakeven, but it was not enough to offset declines elsewhere.
Balance Sheet Pressure and Related-Party Deals
Beyond the income statement, investors focused on deteriorating cash generation and leverage. Free cash flow turned negative at $167 million, driven by weaker earnings and inventory build-ups in Brazil tied to the 2027 China quota cycle. Net leverage climbed to 3.54x trailing adjusted EBITDA, up from 2.39x a year earlier, heightening sensitivity around the company's debt burden. The earnings release was also accompanied by the announcement of two acquisitions from controlling shareholder J&F — the $542 million purchase of personal-care and household brand Flora and an $11 million deal for agribusiness media outlet Canal Rural — raising questions about related-party governance and potential share dilution, given that the Flora transaction would be settled largely in JBS stock.
Market Context and Trading Activity
The selloff in JBS ran counter to a broadly flat U.S. session, underscoring that the move was driven by company-specific news rather than a broad-market rotation. Peers across the global protein sector have been navigating lower meat prices and compressed margins, and the third-quarter results confirmed that these headwinds hit JBS more severely than anticipated. The shares have been trading near levels closer to their 52-week low than their high, and Tuesday's decline reinforces the technical pressure that has built as estimates were revised lower over the past two months.
What Comes Next for JBS
Looking ahead, investors will monitor whether the improvement in U.S. beef margins — which turned positive in September on the back of resumed cattle imports from Mexico — continues into the fourth quarter. Management signaled that Chinese demand strengthened early in the fourth quarter as buyers began securing volumes under the 2027 quota, a development that could support a recovery in Brazilian export volumes. However, risks remain, including persistent leverage at elevated levels, ongoing global trade disruptions, and uncertainty around the governance implications of the newly announced related-party transactions. The trajectory of beef and pork margins across the company's largest segments will be central to whether the current selloff stabilizes.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies. While Tickeron offers hundreds of AI-powered bots covering thousands of tickers, only the strongest performers under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and traded symbols, giving users a way to explore data-driven approaches to the market. Consider exploring the Trending AI Robots page to see which strategies are leading right now.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
JBS saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for JBS moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 62 similar instances where the indicator exited the overbought zone. In 46 of the 62 cases the stock moved lower. This puts the odds of a downward move at 74%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
JBS broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for JBS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on JBS as a result. In 68 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for JBS just turned positive on November 04, 2026. Looking at past instances where JBS's MACD turned positive, the stock continued to rise in 28 of 43 cases over the following month. The odds of a continued upward trend are 65%.
JBS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for JBS crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 46%.
Following a +5.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where JBS advanced for three days, in 202 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.992) is normal, around the industry mean (6.914). P/E Ratio (11.664) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (8.458). JBS's Dividend Yield (0.321) is considerably higher than the industry average of (0.049). P/S Ratio (0.441) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. JBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry FoodMajorDiversified
Advertisement